daniel
zerr
nicol
h
tobin
ann
j
melvin
p
e
r
l
obtain
serum
store
futur
serolog
test
viral
pathogen
consid
potenti
caus
critic
ill
diagnost
sensit
gener
enhanc
sampl
viral
cultur
stain
sent
earli
possibl
cours
ill
sampl
obtain
fluoresc
antibodi
whether
herp
viru
respiratori
pathogen
contain
adequ
cell
initi
empir
treatment
acyclovir
rapidli
herp
simplex
viru
enceph
neonat
diseas
suspect
initi
appropri
infect
control
precaut
earli
prevent
spread
infect
staff
patient
viral
pathogen
suspect
viral
infect
frequent
caus
diseas
individu
age
gener
spectrum
ill
vari
howev
young
children
suppress
defici
immun
system
higher
risk
sever
diseas
chapter
cover
viral
caus
entiti
commonli
seen
intens
care
unit
myocard
hepat
pneumon
meningitisenceph
content
focus
caus
diagnosi
treatment
attempt
provid
reader
guidanc
initi
manag
patient
seriou
viral
diseas
term
diagnosi
specif
antivir
therapi
although
mani
infecti
noninfecti
caus
identifi
virus
account
case
myocard
spectrum
diseas
rang
asymptomat
minim
chang
electrocardiogram
ecg
fulmin
rapid
onset
sever
diseas
patient
indol
ill
may
progress
dilat
cardiomyopathi
vari
present
difficulti
establish
definit
diagnosi
true
incid
myocard
unknown
larg
seri
sweden
myocardi
biopsi
autopsi
conduct
period
fulfil
dalla
criteria
myocard
although
pathogenesi
viral
myocard
well
understood
myocardi
damag
thought
occur
least
part
direct
result
viral
infect
activ
viral
replic
lead
myocardi
necrosi
coxsacki
viru
proteas
cleav
dystrophin
cultur
myocyt
infect
mous
heart
result
impair
dystrophin
function
poor
myocyt
contractil
addit
humor
cellular
immun
respons
contribut
pathogenesi
myocard
postinfecti
autoimmun
process
cytotox
lymphocyt
c
h
p
e
r
antibodydepend
cellmedi
cytotox
cytokin
may
also
caus
direct
myocardi
injuri
affect
cardiac
function
virus
frequent
associ
myocard
enterovirus
particularli
coxsacki
viru
b
adenovirus
serotyp
mani
virus
caus
myocard
children
includ
influenza
herp
simplex
viru
hsv
human
immunodefici
viru
hiv
cytomegaloviru
cmv
respiratori
syncyti
viru
rsv
mump
measl
virus
widespread
use
measlesmumpsrubella
mmr
vaccin
tabl
polymeras
chain
reaction
pcr
cardiac
tissu
endomyocardi
biopsi
specimen
children
clinic
diagnosi
myocard
identifi
adenoviru
enteroviru
hsv
addit
enterovirus
adenoviru
cmv
increasingli
recogn
import
caus
myocard
adolesc
adult
adenovirus
enterovirus
virus
frequent
identifi
patient
dilat
cardiomyopathi
infant
myocard
usual
symptom
includ
poor
feed
fever
irrit
listless
physic
find
consist
congest
heart
failur
enterovir
myocard
infanc
frequent
occur
conjunct
sever
hepat
pneumon
difficult
distinguish
bacteri
sepsi
death
rate
may
high
sever
dysrhythmia
describ
infant
myocardi
involv
rsv
viral
myocard
implic
case
sudden
infant
death
older
children
adolesc
like
appear
examin
prodrom
viral
ill
earli
symptom
includ
lethargi
lowgrad
temperatur
decreas
appetit
may
diaphoresi
dyspnea
exert
malais
palpit
chest
pain
frequent
symptom
seri
adult
patient
rest
tachycardia
disproportion
amount
fever
common
apic
systol
murmur
may
heard
subset
children
adult
fulmin
myocard
character
rapid
onset
symptom
sever
hemodynam
compromis
fever
laboratori
abnorm
may
includ
elev
white
blood
cell
count
erythrocyt
sediment
rate
serum
aspart
aminotransferas
level
often
elev
creatinin
kinasemb
level
cardiac
troponin
ctni
may
sensit
measur
cardiac
muscl
injuri
myocard
electrocardiograph
abnorm
almost
alway
present
acut
myocard
find
lowvoltag
qr
complex
nonspecif
st
wave
chang
atrial
ventricular
arrhythmia
may
present
includ
supraventricular
ventricular
tachycardia
well
conduct
abnorm
echocardiographi
reveal
left
ventricular
dysfunct
either
segment
wall
motion
abnorm
global
hypokinesi
case
pericardi
effus
common
one
seri
nondil
thicken
hypocontractil
left
ventricl
lv
seen
subject
fulmin
myocard
compar
signific
lv
dilat
normal
lv
thick
subject
insidi
onset
subject
fulmin
myocard
evid
inflamm
endomyocardi
biopsi
like
recov
ventricular
function
pulmonari
edema
enlarg
cardiac
silhouett
promin
pulmonari
vasculatur
may
seen
chest
radiograph
fulmin
hepat
failur
fhf
rare
condit
avail
orthotop
liver
transplant
carri
death
rate
fhf
defin
rapid
develop
jaundic
hepat
encephalopathi
person
without
histori
liver
diseas
relationship
time
cours
symptom
prognosi
classif
scheme
suggest
hyperacut
acut
subacut
liver
failur
interv
week
week
week
appear
jaundic
encephalopathi
signific
overlap
caus
prognos
differ
class
approxim
case
hepat
failur
caus
viral
infect
although
less
infect
virus
result
fhf
hepatotrop
virus
hepat
b
caus
case
fhf
definit
viral
diagnosi
studi
adult
fhf
found
hepat
caus
hepat
b
report
case
greater
percentag
case
fhf
children
may
due
hepat
mani
virus
implic
fulmin
hepat
includ
hepat
c
e
g
well
hsv
infant
perinat
acquir
hepat
b
c
rare
symptom
fulmin
hepat
infant
like
associ
system
ill
due
enterovirus
hsv
human
herpesviru
cmv
infant
born
women
hbsag
hepat
b
surfac
antigen
antihbeab
hepat
b
eantibodi
appear
greater
risk
fulmin
hepat
due
perinat
acquir
hepat
b
infect
hepat
c
rare
caus
fhf
howev
case
report
fulmin
hepat
postnat
perinat
acquir
hepat
c
children
preval
hepat
c
viru
hcv
infect
caus
fhf
appear
geograph
variabl
studi
unit
state
europ
fail
show
presenc
hcvrna
patient
nona
nonb
fhf
howev
sever
japanes
seri
hcvrna
shown
signific
number
patient
nona
nonb
fhf
coinfect
hepat
b
viru
hbv
hcv
associ
wors
prognosi
hsv
consid
caus
fhf
particularli
patient
minim
elev
bilirubin
level
risk
factor
hsv
hepat
includ
pregnanc
immun
suppress
hepat
e
viru
hev
enter
transmit
viru
caus
epidem
hepat
mani
area
world
particularli
indian
subcontin
southeast
asia
endem
western
countri
symptom
acut
hepat
includ
jaundic
anorexia
fatigu
nausea
vomit
fulmin
diseas
rapid
progress
hepat
failur
encephalopathi
physic
examin
may
reveal
fever
hepatosplenomegali
etiolog
agent
viral
pneumonia
vari
tabl
identifi
approxim
case
rsv
respons
sever
viral
respiratori
ill
account
approxim
hospit
death
year
infant
young
children
usual
primari
rsv
infect
symptomat
repeat
infect
involv
lower
respiratori
tract
approxim
time
repeat
infect
common
healthi
host
local
upper
respiratori
tract
infect
infant
may
sever
coinfect
newli
discov
viru
human
metapneumoviru
influenza
epidem
occur
annual
signific
morbid
death
young
children
older
individu
infect
infant
younger
month
may
symptom
mimick
bacteri
sepsi
commonli
includ
apnea
children
younger
year
influenza
caus
symptom
laryngotracheobronch
wherea
pneumonia
occur
younger
year
final
older
children
gener
classic
flulik
symptom
fever
headach
myalgia
malais
upper
respiratori
tract
symptom
bacteri
superinfect
common
potenti
sever
complic
influenza
parainfluenza
common
agent
acut
laryngotrach
children
age
month
year
also
common
caus
upper
respiratori
tract
infect
infant
immunocompromis
host
howev
parainfluenza
caus
bronchiol
pneumonia
immunocompromis
host
parainfluenza
pneumonia
proven
lower
tract
diseas
death
rate
unlik
rsv
lower
tract
diseas
rsv
usual
singl
pathogen
copathogen
identifi
parainfluenza
pneumonia
time
treatment
parainfluenza
pneumonia
includ
coverag
copathogen
addit
inform
rsv
parainfluenza
influenza
measl
adenoviru
avail
chapter
although
cmv
usual
caus
rel
benign
diseas
immunocompet
host
frequent
sever
often
fatal
immunocompromis
host
larg
dna
viru
infect
epitheli
cell
leukocyt
cellular
damag
caus
directli
viral
lytic
infect
indirectli
immun
respons
host
risk
factor
cmv
diseas
includ
seroposit
donor
allogen
transplant
human
leukocyt
antigen
hla
mismatch
age
older
year
develop
graftversushost
diseas
cmv
occur
median
time
day
transplant
rare
engraft
pneumon
sever
diffus
interstiti
infiltr
death
rate
cmv
pneumon
greater
even
ganciclovir
cmv
immunoglobulin
administ
hantavirus
known
caus
hemorrhag
fever
acut
sever
respiratori
infect
young
adult
hantavirus
spread
mammal
mammal
includ
human
exposur
aerosol
fece
infect
urin
secret
unit
state
sin
nombr
viru
caus
pulmonari
syndrom
found
deer
mice
rural
area
north
america
hantavirus
caus
diseas
creat
leakag
plasma
erythrocyt
vascular
endothelium
lung
hantaviru
pulmonari
syndrom
hp
kidney
hemorrhag
fever
syndrom
differenti
diagnosi
includ
influenza
legionella
chlamydia
pneumonia
pneumocysti
carinii
despit
current
therapi
hp
fatal
clinic
case
hantaviru
pulmonari
syndrom
also
discuss
chapter
sever
acut
respiratori
syndrom
sar
result
lifethreaten
atyp
pneumonia
caus
novel
coronaviru
name
sar
viru
viru
thought
deriv
anim
reservoir
potenti
palm
civet
raccoon
dog
cross
human
guangdong
provinc
china
fall
sar
spread
close
contact
infect
human
mostli
household
contact
health
care
worker
incub
period
day
case
definit
sar
continu
evolv
see
wwwcdcgovsar
updat
suspect
individu
meet
clinic
criteria
moder
sever
respiratori
ill
unknown
caus
epidemiolog
criteria
exposur
moder
respiratori
ill
defin
temperatur
greater
f
one
clinic
find
respiratori
ill
eg
cough
short
breath
difficulti
breath
hypoxia
sever
respiratori
ill
defin
moder
respiratori
ill
plu
radiograph
evid
pneumonia
respiratori
distress
syndrom
autopsi
find
consist
pneumonia
respiratori
distress
syndrom
epidemiolog
criteria
includ
travel
includ
transit
airport
within
day
onset
symptom
area
current
previous
document
suspect
commun
transmiss
sar
close
contact
within
day
onset
symptom
person
known
suspect
sar
death
progress
respiratori
failur
occur
approxim
adult
patient
children
morbid
less
death
rare
occur
clinic
present
viral
pneumoniapneumon
usual
consist
fever
increas
respiratori
rate
cough
increas
work
breath
grunt
flare
retract
use
accessori
muscl
infant
young
children
decreas
oral
intak
increas
insens
loss
due
increas
respiratori
rate
often
present
may
lead
dehydr
patient
central
mediat
apnea
patient
overwhelm
sepsislik
syndrom
increas
peripher
puls
decreas
central
blood
pressur
lethargi
histori
examin
find
certain
symptom
includ
rhinorrhea
conjunct
otiti
media
previou
exposur
ill
child
adult
immedi
rais
suspicion
viral
caus
radiograph
find
gener
includ
evid
hyperinfl
peribronchi
cuf
focal
diffus
infiltr
may
may
present
clinic
featur
hp
noncardiogen
pulmonari
edema
includ
prodrom
fever
headach
myalgia
usual
nausea
diarrhea
day
onset
cough
dyspnea
tachycardia
tachypnea
hypotens
develop
rapidli
progress
acut
respiratori
distress
syndrom
ard
laboratori
find
includ
leukocytosi
abnorm
increas
lymphocyt
thrombocytopenia
prolong
partial
thromboplastin
time
ptt
sever
case
rapidli
evolv
diffus
bilater
interstiti
infiltr
seen
chest
radiograph
sar
adolesc
adult
similar
present
hp
initi
infect
character
fever
patient
chill
rigor
develop
dri
nonproduct
cough
dyspnea
day
later
associ
symptom
includ
malais
headach
dizzi
chest
pain
sore
throat
vomit
diarrhea
oxygen
satur
less
patient
present
sever
hypoxemia
develop
diseas
progress
children
frequent
seen
cough
rhinorrhea
rather
chill
rigor
laboratori
find
children
includ
lymphopenia
rather
lymphocytosi
thrombocytopenia
anemia
leukopenia
elev
lactat
dehydrogenas
creatin
kinas
alt
may
also
seen
earli
diseas
chest
radiograph
often
normal
peripheralpleuralbas
opac
abnorm
asept
mening
enceph
myeliti
inflammatori
condit
central
nervou
system
cn
mening
brain
spinal
cord
respect
diseas
caus
varieti
infecti
pathogen
virus
caus
diseas
virus
gain
entri
cn
via
bloodstream
enterovirus
arbovirus
direct
neuron
spread
hsv
rabi
pathogenesi
may
involv
direct
viral
invas
vigor
virusspecif
immun
respons
result
damag
neuron
support
cell
altern
infect
may
trigger
activ
immun
respons
specif
oligodendroglia
myelin
compon
latter
case
diseas
may
follow
upper
respiratori
tract
infect
primarili
take
form
demyelin
process
diseas
commonli
term
postinfecti
encephalomyel
acut
dissemin
encephalomyel
individu
age
risk
cn
viral
infect
neonat
older
individu
immun
defici
prone
frequent
seriou
cn
viral
infect
though
potenti
viral
caus
multipl
howev
enterovirus
herpesvirus
arbovirus
respons
diseas
tabl
enterovirus
account
case
asept
mening
caus
identifi
enteroviru
mening
older
children
adult
typic
selflimit
associ
complic
contrast
enterovir
infect
neonat
may
mimic
bacteri
sepsi
cn
involv
often
manifest
enceph
hsv
common
caus
cn
infect
individu
age
neonat
period
type
lesser
extent
type
caus
enceph
vertic
transmiss
viru
contrast
older
children
adult
hsv
enceph
caus
type
hsv
howev
caus
benign
asept
mening
associ
primari
recurr
genit
infect
member
herpesviru
famili
cmv
epsteinbarr
viru
ebv
varicellazost
viru
vzv
also
caus
asept
mening
enceph
though
less
common
cmv
enceph
occur
mostli
immunosuppress
individu
may
occasion
appear
otherwis
healthi
individu
ebv
asept
mening
enceph
present
without
classic
find
infecti
mononucleosi
acut
cerebellar
ataxia
common
usual
benign
complic
chickenpox
vzv
enceph
sometim
occur
immunocompet
individu
frequent
occur
immunocompromis
individu
follow
day
week
month
varicella
zoster
zoster
enceph
complic
small
larg
vessel
vascul
granulomat
arter
carri
potenti
seriou
consequ
infarct
rare
report
caus
enceph
healthi
children
primari
infect
wherea
appear
common
problem
immunosuppress
patient
receiv
stem
cell
transplant
arbovirus
arthropodspread
virus
import
caus
asept
mening
enceph
specif
arboviru
determin
epidemiolog
morbid
risk
death
associ
diseas
la
cross
st
loui
enceph
virus
account
arbovir
cn
infect
unit
state
la
cross
viru
found
lifethreaten
viral
diseas
treatment
mainli
midwest
typic
occur
summer
earli
fall
associ
rel
low
death
rate
st
loui
enceph
viru
occur
everi
state
common
midwest
florida
texa
respons
larg
urban
outbreak
eastern
equin
viru
occur
less
frequent
mainli
northeast
southeast
carri
high
rate
morbid
death
west
nile
viru
enceph
first
appear
unit
state
summer
new
york
state
follow
summer
west
nile
viru
move
southward
westward
across
unit
state
infect
anim
human
individu
infect
west
nile
viru
symptom
free
experi
flulik
ill
howev
older
individu
underli
immun
defici
experi
enceph
may
result
death
addit
typic
present
enceph
acut
flaccid
paralysi
also
associ
west
nile
viru
infect
number
virus
infrequ
caus
enceph
includ
mump
influenza
lymphocyt
choriomening
virus
lcmv
histor
mump
viru
account
larg
proport
asept
mening
enceph
case
unit
state
current
widespread
use
trival
mmr
vaccin
mening
enceph
due
mump
extrem
rare
influenza
associ
encephalitisencephalopathi
especi
japan
nation
survey
repres
season
case
occur
children
younger
year
report
lcmv
infrequ
recogn
caus
meningoenceph
viru
found
urin
drop
saliva
infect
mice
guinea
pig
hamster
diseas
human
aris
exposur
substanc
postinfecti
encephalomyel
refer
acut
selflimit
demyelin
process
commonli
follow
viral
respiratori
infect
varicella
contrast
subacut
scleros
panenceph
sspe
progress
multifoc
leukoencephalopathi
pml
two
chronic
usual
fatal
demyelin
diseas
due
measl
jc
viru
respect
sspe
commonli
follow
year
natur
measl
infect
sspe
extrem
rare
unit
state
howev
may
occur
often
one
case
per
popul
area
world
mmr
vaccin
wide
use
pml
also
rare
usual
affect
acquir
immun
defici
syndrom
aid
rare
seriou
immunodefici
transvers
myeliti
frequent
associ
enterovirus
howev
vzv
cmv
influenza
hepat
report
caus
even
immunolog
normal
individu
histor
clue
physic
find
help
focus
search
etiolog
agent
travel
resid
area
arbovirus
endem
appropri
season
arthropod
transmiss
typic
summer
month
histori
evid
insect
bite
rais
suspicion
arbovirus
season
also
play
role
enterovir
diseas
temper
climat
enterovirus
preval
summer
fall
month
histori
mother
recent
symptom
consist
viral
ill
fever
sore
throat
gastroenter
rash
rais
suspicion
enteroviru
neonat
enceph
sepsislik
ill
vzv
enceph
myeliti
typic
follow
chickenpox
zoster
week
month
commonli
occur
older
individu
immunosuppress
transplant
recipi
vzv
enceph
may
complic
cn
vasculopathi
result
infarct
chronic
encephalitismening
due
enterovirus
occur
individu
agammaglobulinemia
chronic
relaps
enceph
may
also
due
vzv
measl
sspe
rubella
progress
rubella
panenceph
though
latter
two
extrem
rare
current
widespread
use
mmr
vaccin
hiv
may
caus
encephalopathyenceph
may
also
associ
certain
opportunist
infect
pml
signific
exposur
rodent
drop
rais
concern
lcmv
final
histori
exposur
bat
rais
concern
rabi
classic
clinic
present
viral
mening
character
acut
onset
fever
headach
photophobia
vomit
nuchal
rigid
chronic
present
might
indic
enterovir
diseas
immunosuppress
host
wherea
recurr
asept
mening
associ
hsv
enceph
character
acut
onset
fever
sign
encephalopathi
depress
conscious
focal
neurolog
find
seizur
chronic
progress
present
might
indic
unusu
caus
pml
sspe
transvers
myeliti
character
abrupt
onset
weak
limb
progress
flaccid
paralysi
diminish
deep
tendon
reflex
progress
nonexist
associ
sensori
deficit
vzv
myeliti
usual
follow
varicella
zoster
week
cerebrospin
fluid
csf
find
asept
mening
typic
includ
normal
glucos
level
normal
slightli
elev
protein
level
pleocytosi
cellsmm
pleocytosi
classic
monocyt
howev
initi
predomin
polymorphonuclear
cell
first
hour
ill
csf
find
enceph
normal
may
pleocytosi
elev
protein
level
result
brain
comput
tomographi
ct
magnet
reson
imag
mri
studi
usual
normal
viral
mening
wherea
diseas
often
seen
set
viral
encephalitid
gener
ct
scan
rel
insensit
detect
acut
enceph
mri
sensit
studi
detect
diseas
abil
detect
alter
water
content
acut
viral
enceph
earli
find
includ
edema
minim
contrast
enhanc
diseas
progress
edema
enhanc
becom
obviou
may
accompani
mass
effect
hemorrhag
chang
necrosi
inflamm
resolv
atrophi
may
becom
promin
hsv
imag
studi
may
reveal
edema
enhanc
often
time
first
involv
tempor
lobe
subsequ
spread
area
brain
chang
ultim
progress
atrophi
multicyst
encephalomalacia
gyriform
high
attenu
especi
children
postinfecti
encephalomyel
lesion
may
seen
throughout
cn
lesion
readili
elucid
mri
primarili
involv
white
matter
although
gray
matter
may
also
involv
increas
foreign
travel
threat
bioterror
potenti
treat
child
exot
viral
diseas
exist
although
discuss
infect
includ
and
viru
b
viru
monkeypox
hemorrhag
fever
virus
ebola
viru
marburg
viru
lassa
viru
crimeancongo
hemorrhag
fever
viru
argentin
hemorrhag
fever
viru
bolivian
hemorrhag
fever
viru
beyond
scope
chapter
infect
kept
mind
one
agent
suspect
patient
patient
garment
contain
singl
room
infect
control
infecti
diseas
public
health
depart
call
immedi
key
diagnosi
viral
pathogen
highqual
specimen
obtain
earli
cours
diseas
five
main
way
diagnos
viral
infect
identif
viru
cell
cultur
observ
characterist
cytopath
effect
identif
viru
assay
link
specif
antibodi
viral
antigen
complement
fixat
neutral
immunofluoresc
assay
enzymelink
immunosorb
assay
elisa
microscop
identif
characterist
viral
inclus
bodi
serolog
procedur
show
either
earli
antibodi
immunoglobulin
igm
fourfold
higher
rise
igg
antibodi
titer
acut
phase
convalesc
phase
least
day
later
serum
molecular
techniqu
amplifi
target
viral
dna
rna
viral
caus
suspect
diagnost
studi
perform
immedi
acutephas
serum
held
later
interpret
critic
specimen
drawn
administr
intraven
immunoglobulin
ivig
blood
product
viral
cultur
collect
appropri
site
dacron
swab
plastic
shaft
cotton
wood
inhibit
viral
growth
virolog
laboratori
inform
diagnosi
suspect
pathogen
cell
line
chosen
inocul
vari
viru
suspect
nasal
wash
swab
base
vesicl
ulcer
vzv
hsv
includ
good
cellular
content
fluoresc
antibodi
assay
stain
cell
cell
avail
sensit
assay
isol
viru
myocardium
provid
definit
viral
diagnosi
myocard
howev
recoveri
virus
myocardium
cultur
rare
possibl
even
case
histolog
proven
myocard
viral
cultur
peripher
specimen
stool
nasopharyng
secret
demonstr
fourfold
rise
specif
viral
antibodi
titer
provid
indirect
determin
causal
howev
sensit
also
low
respect
molecular
biolog
techniqu
pcr
situ
hybrid
expand
number
virus
implic
etiolog
myocard
addit
increas
sensit
pcr
applic
pcr
viral
nucleic
acid
myocardi
tissu
provid
virolog
diagnosi
case
viral
diagnosi
reli
serolog
test
detect
viral
nucleic
acid
serum
detect
viral
antigen
nucleic
acid
tissu
obtain
liver
biopsi
specimen
hepat
viru
hav
infect
confirm
detect
antihav
igm
antibodi
patient
acut
hepat
antihav
igm
antibodi
detect
serum
onset
symptom
peak
week
onset
symptom
becom
undetect
month
infect
presenc
hbsag
serum
indic
activ
hbv
replic
present
acut
chronic
hbv
infect
destruct
activ
infect
hepatocyt
hbsag
may
absent
fhf
marker
acut
hbv
infect
may
antihepat
b
core
antibodi
antihbcab
antihbv
core
igm
antibodi
hepat
b
dna
also
detect
serum
liver
tissu
pcr
absenc
hbsag
hbvdna
serum
rule
hbv
caus
fhf
hbv
dna
shown
liver
tissu
patient
nona
nonb
fhf
serolog
marker
suggest
hbv
infect
hepat
hepatotrop
viru
caus
infect
presenc
activ
hepat
b
infect
look
patient
acut
hbv
hepat
coinfect
superinfect
hdv
may
result
sever
diseas
hepat
coinfect
determin
antihdv
antibodi
hdvrna
serum
although
newer
gener
antibodi
assay
hepat
c
sensit
past
assay
antihbcab
may
detect
earli
diseas
therefor
epidemiolog
find
suggest
possibl
infect
hcv
serum
liver
tissu
analyz
hcvrna
pcr
detect
hevrna
blood
liver
confirm
acut
infect
hev
hsv
hepat
frequent
result
newli
acquir
infect
thu
serolog
test
may
help
ulcer
mucos
lesion
present
cultur
hsv
liver
tissu
sent
viral
cultur
pcr
hsv
pcr
may
also
determin
hsv
blood
fluoresc
assay
nasal
wash
specimen
diagnost
test
choic
pathogen
concentr
nasopharynx
sensit
indirect
immunofluoresc
assay
greater
sensit
rsv
parainfluenza
influenza
lifethreaten
viral
diseas
treatment
b
rapid
immunoassay
rsv
influenza
also
avail
adenoviru
immunofluoresc
assay
avail
laboratori
sensit
gener
lower
around
shell
vial
assay
increas
sensit
although
usual
perform
cmv
also
perform
adenoviru
sampl
sent
cultur
addit
immunofluoresc
studi
done
immunocompromis
sever
ill
children
csf
blood
throat
swab
collect
evalu
one
make
diagnosi
enteroviru
cultur
viru
csf
detect
viru
csf
use
revers
transcriptasepcr
greater
sensit
pcr
compar
cultur
use
whenev
possibl
viral
cultur
throat
swab
may
also
reveal
enteroviru
indic
current
recent
infect
rectal
stool
viral
cultur
less
help
enterovirus
may
shed
stool
week
infect
dna
pcr
csf
offer
rel
sensit
specif
diagnosi
herpesvirus
detect
viral
specif
antibodi
csf
add
support
evid
addit
detect
dna
plasma
serum
pcr
confirm
activ
system
viral
replic
arbovirus
typic
diagnos
detect
antibodi
acut
convalesc
serum
specimen
csf
may
also
test
antibodi
pcr
immunohistochemistri
also
use
diagnos
arbovir
infect
avail
set
diagnosi
lcmv
made
serolog
test
jc
viru
detect
csf
pcr
appear
rel
sensit
specif
method
diagnos
pml
definit
diagnosi
howev
usual
made
brain
biopsi
diagnosi
sspe
made
evalu
csf
oligoclon
band
igg
level
specif
measl
antibodi
titer
gener
lifethreaten
viral
infect
primari
treatment
support
improv
intens
medic
care
death
ill
decreas
even
without
avail
specif
antivir
therapi
despit
recent
advanc
effect
antivir
medic
mani
viral
infect
howev
antivir
herp
group
virus
mani
respiratori
virus
infect
efficaci
antivir
therapi
decreas
therapi
delay
earli
diagnosi
rapid
initi
therapi
essenti
consult
infecti
diseas
specialist
recommend
antivir
agent
commerci
avail
new
treatment
modal
continu
identifi
list
antivir
agent
indic
dosag
provid
tabl
mechan
circulatori
support
consid
children
fulmin
myocard
unrespons
standard
manag
aggress
therapi
warrant
adult
children
surviv
ill
good
prognosi
return
normal
ventricular
function
cardiac
transplant
may
necessari
children
refractori
manag
current
recommend
support
use
immunosuppress
therapi
nonsteroid
antiinflammatori
agent
particularli
earli
cours
myocard
treatment
highdos
ivig
associ
improv
left
ventricular
function
sever
small
studi
children
adult
ivig
gener
well
toler
warrant
investig
larger
control
studi
sever
immun
modul
investig
use
treatment
myocard
specif
antivir
therapi
indic
incit
viral
agent
identifi
role
antivir
therapi
fhf
limit
acyclovir
initi
hsv
suspect
confirm
pleconaril
shown
benefit
enterovir
sepsi
control
trial
plasma
exchang
plasmapheresi
shown
improv
hemodynam
paramet
decreas
intracrani
pressur
improv
surviv
experiment
therapi
hepatocyt
transplant
artifici
hepat
support
system
develop
shown
promis
earli
studi
current
orthotop
liver
transplant
provid
primari
treatment
modal
detail
discuss
manag
fhf
see
chapter
refer
cornerston
treatment
remain
support
oxygen
fluid
bronchodil
mechan
ventil
corticosteroid
gener
proven
benefit
viralmedi
pneumonia
data
suggest
benefit
bronchiol
remain
controversi
gener
treatment
rsv
ribavirin
immunocompet
host
shown
clinic
benefit
despit
initi
studi
suggest
modest
clinic
benefit
led
licens
ribavirin
evid
develop
howev
combin
inhal
ribavirin
either
intraven
rsv
immunoglobulin
monoclon
antibodi
may
substanti
decreas
high
death
rate
rsv
pneumonia
bone
marrow
transplant
subject
ribavirin
alon
combin
patient
whose
symptom
suggest
sar
immedi
isol
neg
pressur
room
use
airborn
precaut
respir
papr
power
air
purifi
respir
contact
precaut
gown
glove
hospit
infect
control
local
public
health
depart
need
contact
immedi
treatment
sar
remain
controversi
cdc
websit
wwwcdcgov
infecti
diseas
consult
access
uptod
diagnost
treatment
isol
guidelin
untreat
hsv
enceph
carri
death
rate
excess
even
treat
death
complic
lifethreaten
viral
diseas
treatment
surviv
remain
order
respect
similarli
despit
treatment
neonat
hsv
cn
diseas
carri
signific
risk
death
morbid
rang
respect
earli
identif
patient
rapid
initi
acyclovir
associ
better
outcom
unless
altern
caus
clear
highdos
acyclovir
initi
children
enceph
hsv
rule
specif
antivir
therapi
may
direct
outlin
tabl
current
approv
therapi
pleconoril
mgkg
po
per
nanogram
tid
treatment
enterovir
infect
maximum
dose
mg
yet
approv
fda
avail
compassionateus
basi
neonat
enterovir
sepsi
myocard
chronic
meningoceph
sever
infect
patient
bone
marrow
transplant
vaccineassoci
paralyt
polio
hantaviru
intraven
ribavirin
shown
benefit
hantaviru
renal
syndrom
hantaviru
pulmonari
syndrom
herpesviru
cmv
ganciclovir
mgkg
q
hr
wk
foscarnet
mgkg
q
hr
wk
mgkg
mgkg
q
hr
primari
therapi
q
hr
cidofovir
mgkgwkhigh
risk
renal
cmv
diseas
ivig
mgkg
qod
toxic
use
probenecid
salin
hydrat
wk
weekli
cmvig
increas
efficaci
cidofovir
suggest
allogen
mgkg
schedul
stem
cell
transplant
recipi
cmv
pneumonia
given
concurr
cmv
pneumonia
one
small
studi
immunocompromis
patient
hsv
acyclovir
mgkgdose
iv
q
hr
specif
dose
recommend
avail
enceph
neonat
children
hsvassoci
hepat
pneumon
least
younger
yr
neonat
mgkgdose
consid
outsid
dissemin
diseas
neonat
period
hhv
foscarnet
ganciclovir
vitro
activ
case
report
seri
show
variabl
clinic
respons
one
drug
combin
vzv
acyclovir
mgkgdose
q
hr
high
dose
mgkgdose
use
vzv
enceph
diseas
immunocompromis
children
influenza
ab
oseltamivir
mgkg
bid
daysmax
rimantadin
amantidin
mgkgday
div
bidmax
mg
bid
effect
therapi
hiv
infect
treatment
combin
antiretrovir
therapi
may
improv
surviv
potenti
role
cidofovir
treatment
parainfluenza
pneumonia
includ
coverag
copathogen
ribavirin
ivig
remain
controversi
recent
review
show
benefit
rsv
aerosol
ribavirin
g
reconstitut
combin
therapi
ribavirin
palivizumab
rsv
ml
tid
day
use
monoclon
antibodi
ribavirin
rsvig
may
improv
modest
efficaci
patient
sever
outcom
rsv
pneumonia
immunocompromis
rsv
pneumonia
immunopatientsund
investig
compromis
patientsnot
recommend
uncompl
diseas
cmv
cytomegaloviru
div
divid
human
herpesviru
hiv
human
immunodefici
viru
hsv
herp
simplex
viru
ig
immunoglobulin
iv
intraven
ivig
intraven
immunoglobulin
jcv
jc
viru
max
maximum
rsv
respiratori
syncyti
viru
